Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-096005
Filing Date
2007-04-30
Accepted
2007-04-30 16:29:17
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 356983
2 REGISTRANT'S RESTATED ARTICLES OF INCORPORATION, AS AMENDED dex31.htm EX-3.1 198497
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 7259
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 7285
5 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 6720
  Complete submission text file 0001193125-07-096005.txt   578164
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12465 | Film No.: 07800886
SIC: 2834 Pharmaceutical Preparations